Amrutanjan Income Before Tax vs Interest Expense Analysis

AMRUTANJAN

577.75 15.65 2.64%

Amrutanjan Health financial indicator trend analysis is way more than just evaluating Amrutanjan Health Care prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Amrutanjan Health Care is a good investment. Please check the relationship between Amrutanjan Health Income Before Tax and its Interest Expense accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amrutanjan Health Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Income Before Tax vs Interest Expense

Income Before Tax vs Interest Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Amrutanjan Health Care Income Before Tax account and Interest Expense. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Amrutanjan Health's Income Before Tax and Interest Expense is -0.48. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Interest Expense in the same time period over historical financial statements of Amrutanjan Health Care, assuming nothing else is changed. The correlation between historical values of Amrutanjan Health's Income Before Tax and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of Amrutanjan Health Care are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Income Before Tax i.e., Amrutanjan Health's Income Before Tax and Interest Expense go up and down completely randomly.

Correlation Coefficient

-0.48

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Amrutanjan Health income statement and is an important metric when analyzing Amrutanjan Health Care profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Most indicators from Amrutanjan Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Amrutanjan Health Care current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amrutanjan Health Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

At this time, Amrutanjan Health's Selling General Administrative is very stable compared to the past year. As of the 28th of February 2025, Issuance Of Capital Stock is likely to grow to about 11.4 M, though Discontinued Operations is likely to grow to (4.1 M).

	2022	2023	2024	2025 (projected)
Interest Expense	771K	2.5M	2.3M	2.1M
Depreciation And Amortization	52.1M	60.6M	69.7M	35.2M

Interest Expense Depreciation And Amortization

Amrutanjan Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Term Debt	Short Term Investments	Intangible Assets	Current Deferred Revenue	Retained Earnings
Total Assets		-0.56	-0.1	0.98	1.0	0.78	-0.15	0.19	0.66	-0.31	0.98	0.67	-0.71	0.3	0.95	0.24	-0.2	0.85	0.99	-0.73	0.96	-0.61	0.95	-0.3	-0.02	0.95
Short Long Term Debt Total	-0.56		0.28	-0.44	-0.59	-0.32	0.46	-0.39	-0.25	0.61	-0.59	-0.44	0.29	-0.15	-0.5	-0.23	0.09	-0.42	-0.59	0.3	-0.61	0.88	-0.46	0.28	0.24	-0.46
Other Current Liab	-0.1	0.28		0.01	-0.13	0.15	0.29	-0.27	0.35	-0.04	-0.18	-0.24	0.01	0.4	-0.06	-0.04	0.39	0.07	-0.18	0.01	-0.29	0.58	-0.08	0.6	0.29	-0.06
Total Current Liabilities	0.98	-0.44	0.01		0.97	0.8	-0.15	0.2	0.69	-0.22	0.94	0.67	-0.72	0.29	0.93	0.28	-0.18	0.87	0.96	-0.73	0.94	-0.5	0.9	-0.28	0.06	0.92
Total Stockholder Equity	1.0	-0.59	-0.13	0.97		0.77	-0.16	0.19	0.65	-0.32	0.98	0.67	-0.71	0.29	0.95	0.24	-0.21	0.83	0.99	-0.73	0.97	-0.64	0.94	-0.32	-0.04	0.95
Property Plant And Equipment Net	0.78	-0.32	0.15	0.8	0.77		0.16	-0.17	0.74	-0.14	0.72	0.76	-0.45	0.27	0.73	0.25	-0.05	0.88	0.75	-0.48	0.69	-0.35	0.8	-0.21	0.07	0.76
Net Debt	-0.15	0.46	0.29	-0.15	-0.16	0.16		-0.99	0.15	0.28	-0.25	-0.22	-0.02	0.19	0.01	-0.44	0.16	-0.19	-0.21	-0.03	-0.26	0.48	0.12	0.35	-0.13	-0.01
Cash	0.19	-0.39	-0.27	0.2	0.19	-0.17	-0.99		-0.16	-0.26	0.28	0.21	-0.08	-0.21	0.02	0.41	-0.18	0.18	0.25	-0.07	0.28	-0.44	-0.08	-0.35	0.14	0.04
Non Current Assets Total	0.66	-0.25	0.35	0.69	0.65	0.74	0.15	-0.16		-0.14	0.54	0.48	-0.36	0.42	0.71	0.29	0.08	0.77	0.56	-0.37	0.55	-0.21	0.6	-0.08	0.14	0.66
Non Currrent Assets Other	-0.31	0.61	-0.04	-0.22	-0.32	-0.14	0.28	-0.26	-0.14		-0.34	-0.11	0.07	-0.48	-0.37	-0.13	0.04	-0.23	-0.32	0.08	-0.3	0.32	-0.26	-0.28	-0.01	-0.32
Cash And Short Term Investments	0.98	-0.59	-0.18	0.94	0.98	0.72	-0.25	0.28	0.54	-0.34		0.62	-0.65	0.31	0.91	0.25	-0.2	0.82	0.99	-0.67	0.96	-0.63	0.93	-0.28	0.03	0.94
Net Receivables	0.67	-0.44	-0.24	0.67	0.67	0.76	-0.22	0.21	0.48	-0.11	0.62		-0.43	-0.08	0.58	0.17	-0.52	0.74	0.67	-0.46	0.71	-0.62	0.55	-0.58	-0.28	0.53
Common Stock Shares Outstanding	-0.71	0.29	0.01	-0.72	-0.71	-0.45	-0.02	-0.08	-0.36	0.07	-0.65	-0.43		0.1	-0.66	0.11	0.18	-0.36	-0.7	1.0	-0.64	0.39	-0.66	0.35	0.29	-0.58
Non Current Liabilities Total	0.3	-0.15	0.4	0.29	0.29	0.27	0.19	-0.21	0.42	-0.48	0.31	-0.08	0.1		0.45	-0.05	0.07	0.41	0.26	0.08	0.26	0.17	0.39	0.74	0.16	0.47
Inventory	0.95	-0.5	-0.06	0.93	0.95	0.73	0.01	0.02	0.71	-0.37	0.91	0.58	-0.66	0.45		0.1	-0.19	0.8	0.93	-0.67	0.92	-0.51	0.94	-0.16	-0.06	0.95
Other Current Assets	0.24	-0.23	-0.04	0.28	0.24	0.25	-0.44	0.41	0.29	-0.13	0.25	0.17	0.11	-0.05	0.1		0.24	0.37	0.23	0.12	0.26	-0.22	0.1	-0.22	0.53	0.25
Other Stockholder Equity	-0.2	0.09	0.39	-0.18	-0.21	-0.05	0.16	-0.18	0.08	0.04	-0.2	-0.52	0.18	0.07	-0.19	0.24		-0.11	-0.24	0.19	-0.32	0.28	-0.15	0.27	0.43	-0.19
Total Liab	0.85	-0.42	0.07	0.87	0.83	0.88	-0.19	0.18	0.77	-0.23	0.82	0.74	-0.36	0.41	0.8	0.37	-0.11		0.82	-0.39	0.82	-0.43	0.77	-0.19	0.18	0.82
Total Current Assets	0.99	-0.59	-0.18	0.96	0.99	0.75	-0.21	0.25	0.56	-0.32	0.99	0.67	-0.7	0.26	0.93	0.23	-0.24	0.82		-0.72	0.97	-0.65	0.94	-0.33	-0.04	0.94
Common Stock	-0.73	0.3	0.01	-0.73	-0.73	-0.48	-0.03	-0.07	-0.37	0.08	-0.67	-0.46	1.0	0.08	-0.67	0.12	0.19	-0.39	-0.72		-0.66	0.4	-0.68	0.34	0.3	-0.6
Accounts Payable	0.96	-0.61	-0.29	0.94	0.97	0.69	-0.26	0.28	0.55	-0.3	0.96	0.71	-0.64	0.26	0.92	0.26	-0.32	0.82	0.97	-0.66		-0.7	0.89	-0.37	-0.1	0.91
Short Term Debt	-0.61	0.88	0.58	-0.5	-0.64	-0.35	0.48	-0.44	-0.21	0.32	-0.63	-0.62	0.39	0.17	-0.51	-0.22	0.28	-0.43	-0.65	0.4	-0.7		-0.49	0.67	0.34	-0.47
Short Term Investments	0.95	-0.46	-0.08	0.9	0.94	0.8	0.12	-0.08	0.6	-0.26	0.93	0.55	-0.66	0.39	0.94	0.1	-0.15	0.77	0.94	-0.68	0.89	-0.49		-0.16	-0.02	0.96
Intangible Assets	-0.3	0.28	0.6	-0.28	-0.32	-0.21	0.35	-0.35	-0.08	-0.28	-0.28	-0.58	0.35	0.74	-0.16	-0.22	0.27	-0.19	-0.33	0.34	-0.37	0.67	-0.16		0.26	-0.11
Current Deferred Revenue	-0.02	0.24	0.29	0.06	-0.04	0.07	-0.13	0.14	0.14	-0.01	0.03	-0.28	0.29	0.16	-0.06	0.53	0.43	0.18	-0.04	0.3	-0.1	0.34	-0.02	0.26		0.08
Retained Earnings	0.95	-0.46	-0.06	0.92	0.95	0.76	-0.01	0.04	0.66	-0.32	0.94	0.53	-0.58	0.47	0.95	0.25	-0.19	0.82	0.94	-0.6	0.91	-0.47	0.96	-0.11	0.08

Click cells to compare fundamentals

Amrutanjan Health Account Relationship Matchups

Amrutanjan Health fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.7B	3.5B	3.6B	3.7B	4.2B	4.4B
Short Long Term Debt Total	13.4M	8.8M	9.1M	17.3M	15.6M	14.8M
Other Current Liab	66.6M	110.3M	109.1M	110.5M	99.4M	94.2M
Total Current Liabilities	521.0M	774.7M	630.1M	699.2M	804.1M	844.3M
Total Stockholder Equity	2.2B	2.7B	2.9B	2.9B	3.3B	3.5B
Property Plant And Equipment Net	233.2M	434.7M	475.5M	495.4M	569.8M	338.5M
Net Debt	(1.3B)	(826.0M)	(39.9M)	(240.4M)	(216.3M)	(227.1M)
Cash	1.3B	834.8M	49.0M	257.6M	296.3M	428.0M
Non Current Assets Total	513.7M	752.2M	1.0B	711.9M	818.7M	613.8M
Non Currrent Assets Other	25.2M	34.8M	52.1M	45.4M	40.9M	38.8M
Cash And Short Term Investments	1.8B	2.0B	1.9B	2.1B	2.4B	2.5B
Net Receivables	262.8M	425.2M	330.2M	478.9M	550.7M	301.6M
Common Stock Shares Outstanding	29.2M	29.2M	29.2M	29.2M	26.3M	23.8M
Liabilities And Stockholders Equity	2.7B	3.5B	3.6B	3.7B	4.2B	4.4B
Non Current Liabilities Total	66.0M	72.7M	83.1M	84.6M	76.2M	63.3M
Inventory	174.6M	260.0M	288.3M	289.0M	332.4M	349.0M
Other Current Assets	301.0M	475.7M	361.3M	59.6M	68.5M	65.1M
Other Stockholder Equity	510.2M	474.8M	479.6M	(16.2M)	(14.6M)	(13.8M)
Total Liab	587.1M	847.4M	713.2M	783.8M	901.4M	470.5M
Total Current Assets	2.2B	2.7B	2.6B	3.0B	3.4B	3.6B
Accumulated Other Comprehensive Income	519.9M	519.8M	524.2M	510.0M	586.5M	615.8M
Accounts Payable	406.7M	604.5M	474.4M	558.6M	642.4M	674.5M
Short Term Debt	6.4M	5.7M	5.1M	3.3M	3.0M	2.8M
Short Term Investments	446.4M	1.2B	1.9B	1.8B	2.1B	2.2B
Intangible Assets	15.1M	23.2M	24.8M	23.8M	21.4M	18.9M
Current Deferred Revenue	59.4M	99.5M	72.2M	10.6M	12.1M	11.5M
Retained Earnings	1.6B	2.1B	2.9B	2.4B	2.7B	2.9B
Other Liab	57.4M	59.0M	69.6M	79.1M	90.9M	57.0M
Net Tangible Assets	1.6B	2.1B	2.6B	2.9B	3.3B	1.8B
Other Assets	63.9M	71.2M	57.9M	1.0	0.9	0.86
Property Plant Equipment	255.7M	233.2M	434.7M	475.5M	546.8M	335.9M
Long Term Debt Total	11.2M	7.0M	3.1M	4.0M	4.6M	4.0M
Cash And Equivalents	588.0M	60M	0.0	654.1M	752.3M	789.9M
Net Invested Capital	2.2B	2.7B	2.9B	2.9B	3.3B	2.3B
Net Working Capital	1.7B	2.0B	2.0B	2.3B	2.6B	1.7B
Capital Lease Obligations	13.4M	8.8M	9.1M	17.3M	15.6M	10.5M
Property Plant And Equipment Gross	388.7M	622.3M	475.5M	495.4M	569.8M	520.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Amrutanjan Stock

Balance Sheet is a snapshot of the financial position of Amrutanjan Health Care at a specified time, usually calculated after every quarter, six months, or one year. Amrutanjan Health Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Amrutanjan Health and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Amrutanjan currently owns. An asset can also be divided into two categories, current and non-current.

Trending Assets

BETA

Beta Drugs

1,649 0.40 0.02

SALSTEEL

SAL Steel Limited

18.22 -0.76 -4

SALZERELEC

Salzer Electronics

908.10 -58.65 -6.07

ELIN

Elin Electronics

109.97 -7.06 -6.03

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC